Cambridge, Mass. — More than six decades later, Robert Langer still remembers playing with his chemistry set and experimenting with polymers in his youth. Surrounded by walls full of awards and ...
In a partnership spanning 18 years and almost as many startup companies, Robert Langer, serial entrepreneur and MIT institute professor, and Terry McGuire, general partner at Polaris Venture Partners ...
CAMBRIDGE, Mass. and HOUSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide ...
Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.
Robert Langer, a 2024 Kavli Prize laureate in nanoscience and Massachusetts Institute of Technology professor in the departments of chemical and biological engineering, presented his groundbreaking ...
Host Jessica Harris talks with Robert Langer, a chemical engineer who has pioneered the fields of drug delivery and tissue engineering. Harris... Robert Langer, Chemical Engineer At MIT Host Jessica ...
NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases ...
Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr. Langer’s extensive scientific knowledge and experience CAMBRIDGE, Mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results